steer study semaglutide Three reasons why the #ESC2025 of 2.4 mg versus tirzepatide is not appropriate for drawing conclusions: 1. Semaglutide 2.4 mg should be compared against tirzepatide dosing regimen used for Mounjaro: Wegovy and the STEER

Muscle and joint pain tend to be diffuse rather than localized to the stomach or digestive tract, and they typically appear within hours of injection rather than developing gradually

Experts attribute the increase in reported overdoses to the rapid expansion of prescriptions and growing demand for these medications

Signs you should delay your next escalation: nausea that lasts more than 5 days after injection, vomiting more than once per week, diarrhea that disrupts daily activities, or inability to maintain adequate hydration

2) obesity can cause hyperuricaemia, further leading to lipid metabolism disorder and chronic diseases (Fernandes Silva et al., 2019